Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20499131 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Panzem® NCD

Indicates status has not been verified in more than two years